Verrica Pharmaceuticals Inc. | ||||
NGM : VRCA || Location: United States | ||||
$5.92+0.27 (+4.78%) |
0.09 M | 5.6 - 6.03 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 4.397 M |
Feb. 29, 2024 | 4.429 M |
Feb. 15, 2024 | 4.384 M |
Jan. 31, 2024 | 4.428 M |
Jan. 12, 2024 | 5.549 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.54 | -0.53 | 1.60% |
09/30/2023 | -0.37 | -0.54 | -46.58% |
06/30/2023 | -0.21 | -0.24 | -11.94% |
03/31/2023 | -0.19 | -0.15 | 22.60% |
12/31/2022 | -0.20 | -0.14 | 28.72% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 42.419M | Shares Float | 15.074M |
Short Float | 4.397M | Market Cap | 251.12M |
Institution ownership | 42.59% | Insider ownership | 39.702% |
Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
Trailing EPS | -1.48 | Forward EPS | -0.85 |